Question 1

What are the most cited papers from Puracyp (United States)?

Accepted Answer

The most cited paper from Puracyp (United States) is "A Cell-Based Reporter Gene Assay for Determining Induction of CYP3A4 in a High-Volume System" (Judy L. Raucy, Lyndon Warfe, Mei‐Fei Yueh et al., 2002), with 86 citations. Next come "The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression." (74) and "Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes" (62).

Question 2

Which research topics does Puracyp (United States) publish most on?

Accepted Answer

By volume in 2022-now: Dementia and Cognitive Impairment Research, Cerebrovascular and Carotid Artery Diseases and Neurological Disease Mechanisms and Treatments.

Question 3

Which fields of science does Puracyp (United States) work in?

Accepted Answer

In all years, 59% of research at Puracyp (United States) is in Life Sciences, 26% in Health Sciences. Its largest fields are Pharmacology, Toxicology and Pharmaceutics (32%), Medicine (25%), Biochemistry, Genetics and Molecular Biology (25%). It does 2.3× the world's share of Life Sciences.

Question 4

Is Puracyp (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.